LEN vs LIN · rev $34.19B vs P/E 34, rev $33.99B
LEN (LEN) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
LEN currently screens at market cap $0. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the LEN and LIN stock pages for the full models.
Not investment advice.